Collectively, these results indicate that RP5-998N21.4 might regulate immune defense-related pathways by promoting the transcription of IFIT2, IFIT3, or ANXA3, which are involved in the pathophysiology of schizophrenia. This evidence concerns the gene ANXA3 and schizophrenia.